SCHEMBL5771713

SCHEMBL5771713

COc1ccc2c(C(=O)O)cccc2c1F

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CDC25B P30305 2/20 0.55
FABP4 P15090 2/20 0.50
CYP2C9 P11712 1/20 0.48
HIF1A Q16665 1/20 0.48
HTT P42858 2/20 0.46
KDM4E B2RXH2 3/20 0.45
ALDH1A1 P00352 3/20 0.45
HPGD P15428 3/20 0.45
HPGDS O60760 1/20 0.45
HSD17B10 Q99714 1/20 0.45
MRGPRX4 Q96LA9 1/20 0.45
NR4A1 P22736 1/20 0.44
NR4A2 P43354 1/20 0.44
NR4A3 Q92570 1/20 0.44
CA12 O43570 1/20 0.44
CA1 P00915 1/20 0.44
CA2 P00918 1/20 0.44
CA7 P43166 1/20 0.44
CA9 Q16790 1/20 0.44
CA14 Q9ULX7 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5770092 0.86 PLK1 (0.45) CDC25BFABP4KDM4EALDH1A1HPGD
SCHEMBL24895097 0.82 CDC25B (0.56) CDC25BFABP4CYP2C9HIF1AHTT
SCHEMBL4103770 0.81 CDC25B (0.68) CDC25BFABP4CYP2C9HIF1AHTT
SCHEMBL352148 0.81 HTT (0.58) CDC25BFABP4HTTKDM4EALDH1A1
SCHEMBL7113203 0.81 CDC25B (0.55) CDC25BFABP4CYP2C9HIF1AHTT
SCHEMBL10527760 0.81 CDC25B (0.55) CDC25BFABP4CYP2C9HIF1AHTT
SCHEMBL10603405 0.81 CDC25B (0.55) CDC25BFABP4CYP2C9HIF1AHTT
SCHEMBL7113675 0.80 AKR1B10 (0.65) CDC25BFABP4CYP2C9HIF1AHTT
Hydrochloric Acid SCHEMBL14157185 0.80 HTT (0.56) CDC25BFABP4HTTKDM4EALDH1A1
Hydrochloric Acid SCHEMBL10417267 0.79 AKR1B10 (0.63) CDC25BFABP4CYP2C9HIF1AHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1660503-A1 NAPHTHALENE CARBOXAMIDES AND THEIR DERIVATIVES USEFUL AS NEW ANTI-ANGIOGENIC AGENTS PFIZER INC. (US) 2006-05-31 EP disclosed
US-20050070508-A1 Napthalene carboxamides and their derivatives useful as new anti-angiogenic agents AGOURON PHARMACEUTICALS, INC. 2005-03-31 US disclosed
WO-2005021553-A1 NAPHTHALENE CARBOXAMIDES AND THEIR DERIVATIVES USEFUL AS NEW ANTI-ANGIOGENIC AGENTS PFIZER INC. (US) 2005-03-10 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050070508-A1 Napthalene carboxamides and their derivatives useful as new anti-angiogenic agents CCNA1, CCNA2, CCNT1 CDC25B 78/4885FABP4 3548/4885CYP2C9 2105/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.